>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
125I籽源与缓释化疗粒子联合植入靶向治疗进展期胰腺癌
作者:李力军1 封国生1 刘璐2 孙新臣2 高宏1 杨德同2 张文治3 
单位:1.北京铁路总医院,北京,100038; 2.东南大学医学院,江苏,南京,210009; 3.中国人民解放军总医院,北京,100853
关键词:胰腺癌 125I粒子 5-FU缓释化疗粒子 近距离治疗 
分类号:R735.905
出版年·卷·期(页码):2004·23·第四期(246-247)
摘要:

目的:建立放、化疗粒子联合植入法综合治疗进展期胰腺癌.方法:26例进展期胰腺癌中胰头癌19例,胰体癌7例.肿瘤最大直径均大于4 cm,大于5 cm者5例.行内引流术22例.在治疗计划指导下,于术中先植入5-氟尿嘧啶(5-FU)缓释化疗粒子,再植入放射性125I粒子,肿瘤匹配周边剂量(matched peripheral dose, MPD)为60~80 Gy.平均每例使用125I粒子16粒和5-FU 1000 mg.结果:全部病例经过3~19个月随访观察,无手术并发症发生.16例瘤体缩小超过四分之一.26例患者中位生存期为12个月,最长1例随访时间为术后19个月,现仍存活.结论:放射性125I粒子和5-FU缓释化疗粒子联合应用局部植入技术是综合治疗进展期胰腺癌的有效手段之一.

Objective  To establish the combined treatment technique with interstitial implantation of       125I seeds and 5?FU slow-release seeds for advanced pancreatic cancer. Methods  26 cases of advanced pancreatic cancer were treated with radiochemotherapy from August of 2001 to December of 2003, among which 19 cases of caput pancreatic cancer and 7 in pancreatic corpus. The sizes of tumor in 21 cases were larger than 4?cm in diameter,  5 cases larger than 5?cm. 5?FU slow-releasing seeds were first implanted, and then       125I seeds. The MPD of       125I seeds implantation were 60-80?Gy. The internal drainage was performed in 22 cases. The mean 16 granules of       125I seeds and 5?FU 1?000?mg were used in every patient. Results  Fully operating procedure was accomplished for all the patients. Only 2 cases died due to bone and lung metastases in 3 and 4 months postoperatively. The reduced size of tumor was >1/4 in 16 cases. The median survival stage was 12 months. No operating complication occurred. Conclusion  Radiochemotherapy with interstitial implantation of       125I seeds and 5?FU slow-releasing seeds is effective in the treatment of advanced pancreatic cancer.

参考文献:

[1] 王俊杰. 放射性粒子近距离治疗肿瘤, 2001
[2] 刘璐, 孙文豪, 吴复平. 32磷-玻璃微球区域给药治疗肝癌的实验研究和组织吸收剂量估算. 南京铁道医学院学报1997(4)
[3] 刘顺英, 刘璐. 32P-玻璃微球治疗中、晚期消化道癌肿的临床研究. 南京铁道医学院学报1998(4)
[4] 童冠圣, 刘璐, 黄培林. 瘤体内注射32磷-玻璃微球对裸鼠人肝癌移植瘤的抗癌效应研究. 铁道医学2000(6). doi:10.3969/j.issn.1671-7562.2000.06.003
[5] de NITTIS A S, STAMBAUGH M D, LANG P. Complete remission of nonresectable pancreatic cancer after infusional colloidal phosphorus-32 brachytherapy,external beam radiation therapy,and 5-fluorouracil:preliminary report. 1999
[6] 童冠圣, 黄培林, 刘璐. 32P-磷酸铬胶体局部给药在肝癌淋巴道转移小鼠的体内分布. 现代医学2002(6). doi:10.3969/j.issn.1671-7562.2002.06.002
[7] 童冠圣, 黄培林, 刘璐. 放射性32P-磷酸铬胶体治疗H22移植瘤的实验研究. 东南大学学报(医学版)2003(2). doi:10.3969/j.issn.1671-6264.2003.05.001
[8] 赵玉沛. 重视中晚期胰头癌的综合治疗. 胰腺病学2002(2). doi:10.3760/cma.j.issn.1674-1935.2002.01.001
[9] Peretz T. Treatment of primary unresectable carcinoma of the pancreas with 125I implantation, 1998
[10] Raben A. Feasibility study of the treatment of primary unresectable carcinoma of the pancreas with 103Pd brachytherapy, 1996
[11] 李力军. 现代高新技术治疗恶性肿瘤, 2003 

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 418112 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364